A carregar...
Handlungsempfehlung zur Therapieumstellung von Immunsuppressiva auf Dupilumab bei Patienten mit atopischer Dermatitis
Based on new insights into the molecular pathogenesis of atopic dermatitis, a targeted anti-inflammatory therapy—dupilumab—has recently been approved as treatment alongside glucocorticoids and ciclosporin. Due to their pharmacology, neither glucocorticoids nor ciclosporin nor the off label used subs...
Na minha lista:
| Publicado no: | Hautarzt |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Medizin
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8016796/ https://ncbi.nlm.nih.gov/pubmed/33175219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00105-020-04720-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|